Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 2—February 2023
Research Letter

Orthopoxvirus Infections in Rodents, Nigeria, 2018–2019

Clement MesekoComments to Author , Adeyinka Adedeji, Ismaila Shittu, Emmanuel Obishakin, Maurice Nanven, Ladan Suleiman, Daniel Okomah, Visa Tyakaray, Damilola Kolade, Adesola Yinka-Ogunleye, Saleh Muhammad, Clint N. Morgan, Audrey Matheny, Yoshinori Nakazawa, Andrea McCollum, and Jeffrey B. Doty
Author affiliations: National Veterinary Research Institute, Vom, Nigeria (C. Meseko, A. Adedeji, I. Shittu, E. Obishakin, M. Nanven); Federal Ministry of Agriculture and Rural Development, Abuja, Nigeria (L. Suleiman, D. Okomah); African Field Epidemiology Network, Abuja (V. Tyakaray); Nigeria Centre for Diseases Control, Abuja (D. Kolade, A. Yinka-Ogunleye); US Centers for Disease Control and Prevention, Abuja (S. Muhammad); US Centers for Disease Control and Prevention, Atlanta, Georgia, USA (C.N. Morgan, A. Matheny, Y. Nakazawa, A. McCollum, J.B. Doty)

Main Article


Samples positive for OPXV in study of OPXV infections in rodents, Nigeria, 2018–2019*

Rodent species
Animal no.
Sample type
Mus baoulei NG114 Skin biopsy + Not applicable
M. baoulei NG114 Spleen and kidney + Not applicable
M. baoulei NG114 Dried blood spots +
Praomys NG112 Tissues, dried blood spots +
Rattus rattus NG173 Tissues, dried blood spots +

*By quantitative PCR and ELISA. OPXV, orthopoxvirus.

Main Article

Page created: December 20, 2022
Page updated: January 21, 2023
Page reviewed: January 21, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.